Solid Biosciences Inc. SLDB Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s accrued expenses?
- Solid Biosciences Inc. (SLDB) reported accrued expenses of $19.18M in Q1 2026.
- How has Solid Biosciences Inc.'s accrued expenses changed year-over-year?
- Solid Biosciences Inc.'s accrued expenses increased by 31.6% year-over-year, from $14.58M to $19.18M.
- What is the long-term trend for Solid Biosciences Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s accrued expenses has grown at a 17.0% compound annual growth rate (CAGR), from $8.64M to $18.95M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.